Detalhe da pesquisa
1.
Positive experience of intraperitoneal chemotherapy followed by intravenous chemotherapy in heavily pretreated patients with suboptimal residual ovarian cancer and primary peritoneal cancer.
Tumori
; 96(6): 918-25, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21388052
2.
Family history of cancer rather than p53 status predicts efficacy of pegylated liposomal doxorubicin and oxaliplatin in relapsed ovarian cancer.
Int J Gynecol Cancer
; 19(6): 1022-8, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19820363
3.
Tolerability of PLD/oxaliplatin regimen in recurrent ovarian cancer patients with previous fragility to carboplatin/paclitaxel treatment.
Am J Clin Oncol
; 34(3): 305-8, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20622643